CEL-SCI Corporation LSRM.F Stock
CEL-SCI Corporation Price Chart
CEL-SCI Corporation LSRM.F Financial and Trading Overview
| CEL-SCI Corporation stock price | 1.51 EUR |
| Previous Close | 2.22 EUR |
| Open | 2.2 EUR |
| Bid | 2.2 EUR x 0 |
| Ask | 2.26 EUR x 0 |
| Day's Range | 2.2 - 2.2 EUR |
| 52 Week Range | 1.85 - 5.02 EUR |
| Volume | 4.69K EUR |
| Avg. Volume | 119 EUR |
| Market Cap | 98.37M EUR |
| Beta (5Y Monthly) | 1.63345 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.64 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12 EUR |
LSRM.F Valuation Measures
| Enterprise Value | 105.43M EUR |
| Trailing P/E | N/A |
| Forward P/E | 2.972973 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.7826085 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.567 |
Trading Information
CEL-SCI Corporation Stock Price History
| Beta (5Y Monthly) | 1.63345 |
| 52-Week Change | -35.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.02 EUR |
| 52 Week Low | 1.85 EUR |
| 50-Day Moving Average | 2.22 EUR |
| 200-Day Moving Average | 2.7 EUR |
LSRM.F Share Statistics
| Avg. Volume (3 month) | 119 EUR |
| Avg. Daily Volume (10-Days) | 529 EUR |
| Shares Outstanding | 44.71M |
| Float | 43.01M |
| Short Ratio | N/A |
| % Held by Insiders | 3.88% |
| % Held by Institutions | 13.78% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -40.90% |
| Return on Equity (ttm) | -108.43% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -25355346 EUR |
| EBITDA | -29558648 EUR |
| Net Income Avi to Common (ttm) | -35391576 EUR |
| Diluted EPS (ttm) | -0.74 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.08M EUR |
| Total Cash Per Share (mrq) | 0.23 EUR |
| Total Debt (mrq) | 14.46M EUR |
| Total Debt/Equity (mrq) | 71.77 EUR |
| Current Ratio (mrq) | 2.367 |
| Book Value Per Share (mrq) | 0.46 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22841164 EUR |
| Levered Free Cash Flow (ttm) | -7645016 EUR |
Profile of CEL-SCI Corporation
| Country | Germany |
| State | VA |
| City | Vienna |
| Address | 8229 Boone Boulevard |
| ZIP | 22182 |
| Phone | 703 506 9460 |
| Website | https://cel-sci.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research, development, and manufacturing of immune systems for the treatment of cancer and other diseases. The company's lead investigational immunotherapy is Multikine, a Leukocyte Interleukin injection, which has completed a pivotal Phase 3 clinical trial for patients, who are diagnosed with locally advanced primary squamous cell carcinoma of the head and neck. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company is developing CEL-2000 and CEL-4000 which are LEAPS based product candidates for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.
Q&A For CEL-SCI Corporation Stock
What is a current LSRM.F stock price?
CEL-SCI Corporation LSRM.F stock price today per share is 1.51 EUR.
How to purchase CEL-SCI Corporation stock?
You can buy LSRM.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CEL-SCI Corporation?
The stock symbol or ticker of CEL-SCI Corporation is LSRM.F.
Which industry does the CEL-SCI Corporation company belong to?
The CEL-SCI Corporation industry is Biotechnology.
How many shares does CEL-SCI Corporation have in circulation?
The max supply of CEL-SCI Corporation shares is 54.29M.
What is CEL-SCI Corporation Price to Earnings Ratio (PE Ratio)?
CEL-SCI Corporation PE Ratio is now.
What was CEL-SCI Corporation earnings per share over the trailing 12 months (TTM)?
CEL-SCI Corporation EPS is -0.64 EUR over the trailing 12 months.
Which sector does the CEL-SCI Corporation company belong to?
The CEL-SCI Corporation sector is Healthcare.